SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

AbbVie Director Jennifer L. Davis to Resign From Board

Jennifer L. Davis will leave AbbVie’s board effective November 2, 2026, following her appointment as Align Technology CEO.

ABBV

Related stories